期刊文献+

膀胱癌MB49细胞exosomes对MDSCs增殖及活性的影响 被引量:4

Effects of exosomes derived from bladder cancer cell line MB49 on MDSCs expansion and activation
下载PDF
导出
摘要 目的探讨膀胱癌MB49细胞来源的外泌体(exosomes)对MDSCs细胞扩增、活化的影响及机制。方法用超滤联合蔗糖重水密度梯度离心法分离纯化膀胱癌MB49细胞分泌的exosomes;电镜形态学分析及Western blotting鉴定;流式细胞仪检测MDSCs比例;ELISA检测VEGF和IL-6;RT-PCR和Western blotting检测cyclin D1、Arg-1 m RNA和蛋白的表达;Western blotting检测p-STAT3和p-NF-κB的变化。结果成功分离纯化得到膀胱癌MB49细胞分泌的exosomes。exosomes可促进MDSCs扩增及活化。实验组MDSCs比例明显升高;Cyclin D1及Arg-1 m RNA和蛋白的表达均上调;p-STAT3和p-NF-κB的表达也上调。结论膀胱癌MB49细胞来源的exosomes能促使MDSCs细胞扩增、活化。研究和分析MDSCs的免疫抑制机制,为疾病的治疗寻找行之有效的新靶点。 To investigate the effects of exosomes derived from bladder cancer cell line MB49 on the expansion and activation of MDSCs and explore the mechanism,exosomes derived from MB49 cells were separated and purified by ultrafiltration and sucrose gradient centrifugation,then morphology and component of the exosomes were analyzed with electron microscopy and Western blotting respectively. MDSCs proportion was detected by flow cytometry; VEGF and IL-6 produced in culture supernatants were quantified using ELISA kits. The changes of m RNA and protein expressions of cyclin D1,Arg-1 were examined using RT-PCR and Western blotting,and the changes in the protein expression of p-STAT3 and p-NF-κB were detected by Western blotting. Data showed exosomes were successfully purified by ultrafiltration and sucrose gradient centrifugation. Compared with the control cells,MDSCs treated with the exosomes showed enhanced expansion and activation. Exosomes treatment upregulated the m RNA and protein expressions of cyclin D1 and Arg-1,as well as the expressions of p-STAT3 and p-NF-κB. In conclusion,exosomes derived from MB49 can promote the expansion and activation of MDSCs.Research and analysis of MDSCs immunosuppressive mechanism would be helpful to seek new effective targets for disease treatment.
出处 《免疫学杂志》 CAS CSCD 北大核心 2015年第2期127-131,共5页 Immunological Journal
基金 国家自然科学基金(81272572)
关键词 MDSCS 外分泌体 膀胱癌 扩增 活化 MDSCs Exosomes Bladder cancer Expansion Activation
  • 相关文献

参考文献17

  • 1刘秋燕,曹雪涛.MDSCs与肿瘤免疫逃逸[J].中国肿瘤生物治疗杂志,2009,16(4):319-324. 被引量:24
  • 2Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system [J]. Nat Rev Immunol, 2009, 9(3): 162-174.
  • 3陆文彬,沈成兴.MDSC对免疫系统的抑制机制[J].中国免疫学杂志,2011,27(2):188-192. 被引量:10
  • 4Trikha P, Carson WE 3rd. Signaling pathways involved in MDSC regulation[J]. Biochim Biophys Acta, 2014, 1846(1): 55-65.
  • 5Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor ceils as regulators of the immune system [J]. Nat Rev Immunol, 2009, 9(3): 162-174.
  • 6Ugel S, Delpozzo F, Desantis G, et al. Therapeutic targeting of myeloid--derived suppressor cells[]]. Curr Opin Pharmacol, 2009, 9(4): 470-481.
  • 7Xiang X, Poliakov A, Liu C. Induction of myeloid-derived suppressor cells by tumor exosomes[J]. Int J Cancer, 2009, 124(11): 2621-2633.
  • 8Franzen CA, Simms PE, Van Huis AF. Characterization ofuptake and internalization of exosomes by bladder cancer cells[J]. Biomed Res Int, 2014, 2014: 619829.
  • 9Xu XD, Wu XH, Fan YR. Exosome-derived microRNA- 29c induces apoptosis of BIU-87 ceils by down regulating BCL-2 and MCL-I[J]. Asian Pac J Cancer Prey, 2014, 15(8): 3471-3476.
  • 10Talmadge JE. Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy[J]. Clin Cancer Res, 2007, 13(18 Pt 1): 5243-5248.

二级参考文献37

  • 1Liu Q, Zhang C, Sun A, et al. Tumor-educated CD11b^high Ia^low regulatory dendritic cells suppress T cell response through arginase Ⅰ [J]. J Immunol, 2009, 182(10) :6207-6216.
  • 2Chung DJ, Rossi M, Romano E, et al. Indoleamine 2,3-dioxygenase- expressing mature human monocyte-derived dendritic ceils expand potent autologous regulatory T cells [ J]. Blood, 2009,114 (3) : 555 -563.
  • 3Nardin A, Abastado JP. Macrophages and cancer [ J ]. Front Biosci, 2008,13 (3) : 494-505.
  • 4Ko JS, Bukowski RM, Fincke JH. Myeloid-derived suppressor cells: a novel therapeutic target [J]. Curr Oncol Rep, 2009, 11 (2) : 87-93.
  • 5Youn JI, Nagaraj S, Collazo M, et al. Subsets of myeloid-derived suppressor cells in tumor-bearing mice [ J]. J Immunol, 2008, 181 ( 8 ) :5791-5802.
  • 6Hestdal K, Ruscetti FW, Ihle JN, et al. Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells [J]. J Immunol, 1991, 147(1) : 22-28.
  • 7Dietlin TA, Hofman FM, Lund BT, et al. Mycobacteria-induced Gr-1^+ subsets from distinct myeloid lineages have opposite effects on T cell expansion [J]. J Leukoc Biol, 2007, 81 (5) : 1205- 1212.
  • 8Almand B, Clark JI, Nikitina E, et al. Gabrilovich. Increased production of immature myeloid cells in cancer patients : a mechanism of immunosuppression in cancer [ J]. J Immunol, 2001, 166( 1 ) : 678-689.
  • 9Schmielau J, Finn OJ. Activated granulocytes and granulocytederived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients [ J ].Cancer Res, 2001,61 (12) : 4756-4760.
  • 10Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow [J] ? Lancet, 2001, 357(9255): 539-545.

共引文献31

同被引文献20

  • 1Pacheco-Figueiredo L,Antunes L,Bento MJ,et al.Evaluation of the frequency of and survival from second primary cancers in North Portugal:apopulation-based study[J].Eur J Cancer Prev,2013,22(6):599-606.
  • 2Allchorne P,Lamb BW,Kinsella J,et al.Initial experience of intravesical gemcitabine for patients with high-risk superficial transitional cell carcinoma of the bladder following BCG failure[J].Urol Nurs,2014,34(2):95-99.
  • 3Milla P,Fiorito C,Soria F,et al.Intravesical thermo-chemotherapy based on conductive heat:a first pharmacokinetic study with mitomycin C in superficial transitional cell carcinoma patients[J].Cancer Chemother Pharmacol,2014,73(3):503-509.
  • 4Hirata T,Watanabe M,Kaku H,et al.REIC/Dkk-3-encoding adenoviral vector as a potentially effective therapeutic agent for bladder cancer[J].Int J Oncol,2012,41(2):559-564.
  • 5Kaba M,Pirincci N,Benli E,et al.Dickkopf-1levels in Turkish patients with bladder cancer and its association with clinicopathological features[J].Asian Pac J Cancer Prev,2014,15(1):381-384.
  • 6Pili R,Qin R,Flynn PJ,et al.A phaseⅡsafety and efficacy study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor pazopanib in patients with metastatic urothelial cancer[J].Clin Genitourin Cancer,2013,11(4):477-483.
  • 7Laurent VM,Duperray A,Sundar Rajan V,et al.Atomic force microscopy reveals a role for endothelial cell icam-1expression in bladder cancer cell adherence[J].PLoS One,2014,9 (5):e98034.
  • 8Wieczorek E,Reszka E,Jablonowski Z,et al.Genetic polymorphisms in matrix metalloproteinases(MMPs)and tissue inhibitors of MPs(TIMPs),and bladder cancer susceptibility[J].BJU Int,2013,112(8):1207-1214.
  • 9Peng Y,Li L,Huang M,et al.Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway inbladder cancer cells[J].Cell Signal,2014,26(12):2782-2772.
  • 10董自强,江克华,宋兴福,陈先国,陈晓波,袁红纲,刘幼昆,龙兵.抑制PI3K/Akt信号通路提高膀胱癌化疗效果的实验研究[J].实用医学杂志,2012,28(2):181-183. 被引量:7

引证文献4

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部